课题基金 / 基金详情

How does the SARS-CoV-2 antibody response shape patient outcomes? A longitudinal study to evaluate the SARS-CoV-2 antibody response and associations with physiological response and clinical outcomes

How does the SARS-CoV-2 antibody response shape patient outcomes? A longitudinal study to evaluate the SARS-CoV-2 antibody response and associations with physiological response and clinical outcomes
SARS-CoV-2 抗体反应如何影响患者的治疗结果？
批准号：
466664
负责人：
Morgan Gregory J
金额：
$1.27万
依托单位：
University of Toronto
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-12-01 至 2022-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=466664&lang=en
关键词：
Antibodies Biochemical Response Biochemistry Clinical Characteristics Covid-19 Longitudinal Cohort Study Patient Outcomes Sars-Cov-2 Serological Testing Viral Neutralization

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
在COVID-19大流行期间，研究人员和临床医生试图了解为什么人们在感染SARS-CoV-2时症状严重程度会出现巨大差异。免疫系统对SARS-CoV-2感染或产生的抗体
英文摘要
During the COVID-19 pandemic, researchers and clinicians have sought to understand why people experience drastic differences in symptom severity when infected with SARS-CoV-2.Antibodies produced by the immune system in response to SARS-CoV-2 infection or
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金